24:6F-5 - Records on use; periodic studies - New-jersey Statutes

State Codes and Statutes

Statutes > New-jersey > Title-24 > Section-24-6f > 24-6f-5

24:6F-5. Records on use; periodic studies The State Department of Health shall maintain records concerning the use of the substance amygdalin, also known as laetrile or vitamin B-17, and shall make periodic studies, based on such records, concerning the efficacy of such substance in the treatment of cancer. The Commissioner of Health is hereby authorized to promulgate rules and regulations to implement the provisions of this act, including: regulations to prohibit the use of amygdalin unless such substance is prescribed by a physician on the form set out in this act; and regulations to require copies of all such forms, when completed, to be sent to the Department of Health.

L.1977, c. 318, s. 5, eff. Jan. 10, 1978.

State Codes and Statutes

Statutes > New-jersey > Title-24 > Section-24-6f > 24-6f-5

24:6F-5. Records on use; periodic studies The State Department of Health shall maintain records concerning the use of the substance amygdalin, also known as laetrile or vitamin B-17, and shall make periodic studies, based on such records, concerning the efficacy of such substance in the treatment of cancer. The Commissioner of Health is hereby authorized to promulgate rules and regulations to implement the provisions of this act, including: regulations to prohibit the use of amygdalin unless such substance is prescribed by a physician on the form set out in this act; and regulations to require copies of all such forms, when completed, to be sent to the Department of Health.

L.1977, c. 318, s. 5, eff. Jan. 10, 1978.

State Codes and Statutes

Back To Homepage

State Codes and Statutes

Statutes > New-jersey > Title-24 > Section-24-6f > 24-6f-5

24:6F-5. Records on use; periodic studies The State Department of Health shall maintain records concerning the use of the substance amygdalin, also known as laetrile or vitamin B-17, and shall make periodic studies, based on such records, concerning the efficacy of such substance in the treatment of cancer. The Commissioner of Health is hereby authorized to promulgate rules and regulations to implement the provisions of this act, including: regulations to prohibit the use of amygdalin unless such substance is prescribed by a physician on the form set out in this act; and regulations to require copies of all such forms, when completed, to be sent to the Department of Health.

L.1977, c. 318, s. 5, eff. Jan. 10, 1978.